Only a fifth of pharma companies connecting to EU FMD hub

Around 2000 pharmaceutical companies across Europe have not yet started the process of connecting to the European Medicines Verification System (EMVS), also known as the “EU hub”, as part of Falsfied Medicines Directive (FMD) requirements.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research